Paramount Skydance agreed to postpone closing its merger with Warner Bros. Discovery until five days after a state antitrust case opposing the deal is resolved or until June 2027, when its merger agreement expires.
Why it matters: The move, which extends a shorter pause imposed this week by a federal judge in California, brings further uncertainty to the $110 billion megamerger that took many months to broker.
Anthropic on Friday is releasing Claude Opus 5, a new AI model designed to deliver performance close to its most powerful model, Fable, on many tasks at half the price, the company said.
Why it matters: Opus 5 is Anthropic's fourth Claude 5 model release in less than two months, underscoring how AI deployment has shifted from blockbuster launches to rapid improvements on capability, cost and speed.
Nvidia CEO Jensen Huang thinks the artificial intelligence revolution is a wellspring of new jobs, rather than a labor market grim reaper set to bring on the employment apocalypse.
The big picture: Huang's optimism puts him at odds with the dire warnings of a white-collar bloodbath.
Kansas Citians are roughly 500 miles away from the closest movie theater that projects "The Odyssey" in IMAX 70mm.
Why it matters: Movie fans hoping to experience the film exactly as director Christopher Nolan intended might have to embark on an odyssey of their own.
Nvidia CEO Jensen Huang says that despite the chip industry's long history of boom-and-bust behavior, "this time is different."
Why it matters: As the leader of the world's most valuable public company and the most important maker of AI semiconductors, Huang's words carry weight when it comes to an industry that is increasingly driving the markets and the economy.
The pace of AI development combined with soaring compute costs is squeezing the AI researchers responsible for evaluating frontier models — just as those models' capabilities are becoming harder to measure.
Why it matters: When safety testing can't keep pace, models capable of hacking companies or aiding in the development of bioweapons could reach the public before anyone knows what they can do.
